A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies

Shock

Volumn 5, Issue 2, 1996, Pages 116-121

  Aranow, Jonathan S ^a   Zhuang, Jing ^a   Wang, Hailong ^a   Larkin, Vera ^a   Smith, Marianne ^a   Fink, Mitchell P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ARGININE; DRUG DERIVATIVE; ENZYME INHIBITOR; HEMOGLOBIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENTEROBACTER INFECTION; GRAM NEGATIVE INFECTION; LEUKOCYTE COUNT; MALE; METABOLISM; MORTALITY; PERITONITIS; RANDOMIZATION; RAT; SEPSIS; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ARGININE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; ESCHERICHIA COLI INFECTIONS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMOGLOBINS; LEUKOCYTE COUNT; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PERITONITIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 0030076587     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199602000-00006     Document Type: Review

References (43)

1. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB 76:3051-3064, 1992.
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269, 1984.
3. Radomski MW, Palmer RMJ, Moncada S: The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482-1489, 1987.
4. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4654, 1991.
5. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 298:249-258, 1994.
6. Xie QW, Cho HJ, Calaycay J, et al: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228, 1992.
7. Geller DA, Lowenstein C, Shapiro RA, et al: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90:3491-3495, 1993.
8. MacNaul KL, Hutchinson NI: Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 196:1330-1334, 1993.
9. Lelchuk R, Radomski MW, Martin JF, Moncada S: Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther 262:1220-1224, 1992.
10. Asano K, Chee CBE, Gaston B, et al: Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 91:10089-10093, 1994.
11. Markewitz BA, Michael JR, Kohan DE: Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 91:2138-2143, 1993.
12. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:621-626, 1991.
13. Jimenez-Gomez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, Moncada S: L-Arginine:nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253-258, 1995.
14. Szabo C: Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3:2-32, 1995.
15. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
16. Lorente JA, Landin L, de Pablo R, Renes E, Liste D: L-Arginine pathway in the sepsis syndrome. Crit Care Med 21:1287-1295, 1993.
17. Booke M, Meyer J, Lingnau W, Hinder F, Traber LD, Traber DL: Use of nitric oxide synthase inhibitors in animal models of sepsis. New Horizons 3:123-138, 1995.
18. Teale DM, Atkinson AM: Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 30:839-842, 1992.
19. Evans T, Carpenter A, Silva A, Cohen J: Inhibition of nitric oxide synthase in experimental Gram-negative sepsis. J Infect Dis 169:343-349, 1994.
20. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukocyte Biol 48:565-569, 1990.
21. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM: Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129:142-148, 1994.
22. Fukatsu K, Saito H, Fukushima R, Inoue T, Lin M-T, Inaba T, Muto T: Detrimental effects of a nitric oxide synthase inhibitor (N-w-nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch Surg 130:410-414, 1995.
23. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with 5-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
24. Garvey PE, Oplinger JA, Tanoury GJ, et al: Potent and selective inhibition of human nitric oxide synthases: Inhibition by non-amino acid isothioureas. J Biol Chem 269:26669-26676, 1994.
25. Southan GJ, Szabo C, Thiemermann C: Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114:510-516, 1995.
26. Goretski J, Hollocher TC: Trapping of nitric oxide produced during denitrification by extracellular hemoglobin. J Biol Chem 263:2316-2323, 1988.
27. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122:301-308, 1993.
28. Unno N, Menconi MJ, Smith M, Fink MP: Nitric oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 23:1170-1176, 1995.
29. Cook HT, Bune AJ, Jansen AS, Taylor GM, Loi RK, Cattell V: Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci 87:179-186, 1994.
30. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-595, 1990.
31. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172:1132-1138, 1990.
32. Pastor C, Teisseire B, Vicaut E, Payen D: Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 22:465-469, 1994.
33. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR: Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 266:G1004-G1010, 1994.
34. Kilbourne RG, Joly G, Cashon B, DeAngelo J, Bonaventura J: Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsiveness of rat aortic rings to alpha-adrenergic agonists. Biochem Biophys Res Commun 199:155-162, 1994.
35. Crowley JP, Metzger J, Gray A, Pivacek LE, Cassidy G, Valeri CR: Infusion of stroma-free cross-linked hemoglobin during acute Gram-negative bacteremia. Circ Shock 41:144-149, 1993.
36. Pastor CM, Payen DM: Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 2:196-202, 1994.
37. Pastor CM, Billiar TR: Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats. Am J Physiol 268:G177-G182, 1995.
38. Roth RI: Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 83:2860-2865, 1994.
39. Kaka W, Roth RI, Levin J: Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LSP biological activity. J Biol Chem 40:25078-25084, 1994.
40. McFaul SJ, Bowman PD, Villa VM, Gutierrez-Ibanez MJ, Johnson M, Smith D: Hemoglobin stimulates mononuclear cells to release interleukin-8 and tumor necrosis factor α. Blood 84:3175-3181, 1994.
41. Griffiths E, Cortes A, Gilbert N, Stevenson P, MacDonald S, Pepper D: Haemoglobin-based blood substitutes and sepsis. Lancet 345:158-160, 1995.
42. MacMicking JD, Nathan C, Horn G, et al: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995.
43. Wei X-Q, Charles IG, Smith A, et al: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411, 1995.